Serafin W E, Dayton E T, Gravallese P M, Austen K F, Stevens R L
Department of Medicine, Harvard Medical School, Boston, MA.
J Immunol. 1987 Dec 1;139(11):3771-6.
By using a conventional spectrophotometric assay with hippuryl-L-phenylalanine as the substrate, 10(6) BALB/c mouse serosal mast cells possessed 1.5 +/- 0.43 U (mean +/- SE, n = 5, range = 0.48 to 2.5) of carboxypeptidase A activity, while T cell factor-dependent, mouse bone marrow-derived mast cells (BMMC) had barely detectable levels of 0.01 +/- 0.001 U/10(6) cells (mean +/- SE, n = 3). In order to characterize the carboxypeptidase A present in the BMMC, a sensitive assay was developed that used angiotensin I as the substrate and reverse phase-high performance liquid chromatography to separate and quantify production of the cleavage product des-leu-angiotensin I. Using this assay, mouse BMMC carboxypeptidase A had a neutral to basic pH optimum and hydrolyzed angiotensin I with a Km of 0.78 mM. The antigen-induced net percent release of carboxypeptidase A from IgE-sensitized BMMC was proportional to that of the secretory granule component beta-hexosaminidase which indicates a secretory granule location for the exopeptidase. As defined by exclusion during Sepharose CL-2B chromatography, carboxypeptidase A was exocytosed as a greater than 1 X 10(7) m.w. complex bound to proteoglycans. Because BMMC cocultured with mouse skin-derived 3T3 fibroblasts are known to undergo an increase in histamine content and biosynthesis of 35S-labeled heparin proteoglycans, carboxypeptidase A activity was measured during BMMC/fibroblast coculture for 0 to 28 days. The carboxypeptidase A activity increased progressively during 28 days of co-culture from 0.004 +/- 0.002 U/10(6) starting BMMC (mean +/- SE, n = 3) to 0.36 +/- 0.10 U/10(6) co-cultured mast cells. These findings indicate that carboxypeptidase A, a neutral protease, is exocytosed from the secretory granules of mouse mast cells bound to proteoglycan and is increased during the in vitro differentiation of mouse BMMC from mucosal-like mast cells to serosal-like mast cells.
通过使用以马尿酸-L-苯丙氨酸为底物的传统分光光度法测定,10⁶个BALB/c小鼠浆膜肥大细胞具有1.5±0.43 U(平均值±标准误,n = 5,范围为0.48至2.5)的羧肽酶A活性,而T细胞因子依赖性的小鼠骨髓来源肥大细胞(BMMC)的羧肽酶A活性水平极低,仅为0.01±0.001 U/10⁶个细胞(平均值±标准误,n = 3),几乎检测不到。为了表征BMMC中存在的羧肽酶A,开发了一种灵敏的测定方法,该方法以血管紧张素I为底物,并使用反相高效液相色谱法分离和定量裂解产物去亮氨酸血管紧张素I的产生。使用该测定方法,小鼠BMMC羧肽酶A的最适pH为中性至碱性,水解血管紧张素I的Km为0.78 mM。抗原诱导的羧肽酶A从IgE致敏的BMMC中的净释放百分比与分泌颗粒成分β-己糖胺酶的净释放百分比成比例,这表明该外肽酶位于分泌颗粒中。通过在Sepharose CL-2B色谱法中的排阻定义,羧肽酶A以大于1×10⁷分子量的与蛋白聚糖结合的复合物形式胞吐。由于已知与小鼠皮肤来源的3T3成纤维细胞共培养的BMMC中组胺含量增加以及³⁵S标记的肝素蛋白聚糖的生物合成增加,因此在BMMC/成纤维细胞共培养0至28天期间测量了羧肽酶A活性。在共培养的28天中,羧肽酶A活性从起始BMMC的0.004±0.002 U/10⁶个细胞(平均值±标准误,n = 3)逐渐增加至共培养肥大细胞的0.36±0.10 U/10⁶个细胞。这些发现表明,羧肽酶A作为一种中性蛋白酶,以与蛋白聚糖结合的形式从小鼠肥大细胞的分泌颗粒中胞吐,并且在小鼠BMMC从粘膜样肥大细胞向浆膜样肥大细胞的体外分化过程中增加。